Literature DB >> 11201791

Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion.

J Fantini1, D Hammache, G Piéroni, N Yahi.   

Abstract

The fusion of HIV-1 with the plasma membrane of CD4+ cells is triggered by the interaction of HIV-1 surface envelope glycoprotein gp120 with the CD4 receptor, and requires coreceptors (CCR5 and CXCR4). Recent advances in the study of HIV-1 entry into CD4+ cells suggest that glycosphingolipids (GSL) may also participate in the fusion process. GSL are organized in functional microdomains which are associated with specific membrane proteins such as CD4. GSL-enriched microdomains were purified from human lymphocytes and reconstituted as a monomolecular film at the air-water interface of a Langmuir film balance. Surface pressure measurements allowed to characterize the sequential interaction of GSL with CD4 and with gp120. Using this approach, we identified globotriaosylceramide (Gb3) and ganglioside GM3 as the main lymphocyte GSL recognized by gp120. In both cases, the interaction was saturable and dramatically increased by CD4. We propose that GSL microdomains behave as moving platforms allowing the recruitment of HIV-1 coreceptors after the initial interaction between the viral particle and CD4. According to this model, the GSL microdomain may: i) stabilize the attachment of the virus with the cell surface through multiple low affinity interactions between the V3 domain of gp120 and the carbohydrate moiety of GSL, and ii) convey the virus to an appropriate coreceptor by moving freely in the outer leaflet of the plasma membrane. This model can be extrapolated to all envelope viruses (e.g. influenza virus) that use cell surface GSL of the host cells as receptors or coreceptors.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11201791     DOI: 10.1023/a:1026537122903

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  27 in total

1.  Synthetic soluble analogs of glycolipids for studies of virus-glycolipid interactions.

Authors:  J Fantini
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

Review 2.  Structural basis for membrane fusion by enveloped viruses.

Authors:  W Weissenhorn; A Dessen; L J Calder; S C Harrison; J J Skehel; D C Wiley
Journal:  Mol Membr Biol       Date:  1999 Jan-Mar       Impact factor: 2.857

3.  Sulfatide inhibits HIV-1 entry into CD4-/CXCR4+ cells.

Authors:  J Fantini; D Hammache; O Delézay; G Piéroni; C Tamalet; N Yahi
Journal:  Virology       Date:  1998-07-05       Impact factor: 3.616

4.  Sequential interaction of CD4 and HIV-1 gp120 with a reconstituted membrane patch of ganglioside GM3: implications for the role of glycolipids as potential HIV-1 fusion cofactors.

Authors:  D Hammache; N Yahi; G Piéroni; F Ariasi; C Tamalet; J Fantini
Journal:  Biochem Biophys Res Commun       Date:  1998-05-08       Impact factor: 3.575

5.  Evidence for the existence of ganglioside-enriched plasma membrane domains in human peripheral lymphocytes.

Authors:  M Sorice; I Parolini; T Sansolini; T Garofalo; V Dolo; M Sargiacomo; T Tai; C Peschle; M R Torrisi; A Pavan
Journal:  J Lipid Res       Date:  1997-05       Impact factor: 5.922

Review 6.  Virus receptors: binding, adhesion strengthening, and changes in viral structure.

Authors:  A M Haywood
Journal:  J Virol       Date:  1994-01       Impact factor: 5.103

Review 7.  The surface behavior of glycosphingolipids in biomembranes: a new frontier of molecular ecology.

Authors:  B Maggio
Journal:  Prog Biophys Mol Biol       Date:  1994       Impact factor: 3.667

8.  Sendai virus membrane fusion: time course and effect of temperature, pH, calcium, and receptor concentration.

Authors:  A M Haywood; B P Boyer
Journal:  Biochemistry       Date:  1982-11-23       Impact factor: 3.162

9.  Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface.

Authors:  D A Brown; J K Rose
Journal:  Cell       Date:  1992-02-07       Impact factor: 41.582

Review 10.  Sphingolipid organization in biomembranes: what physical studies of model membranes reveal.

Authors:  R E Brown
Journal:  J Cell Sci       Date:  1998-01       Impact factor: 5.285

View more
  15 in total

1.  Time-resolved imaging of HIV-1 Env-mediated lipid and content mixing between a single virion and cell membrane.

Authors:  Ruben M Markosyan; Fredric S Cohen; Grigory B Melikyan
Journal:  Mol Biol Cell       Date:  2005-09-29       Impact factor: 4.138

Review 2.  Glycosphingolipid functions.

Authors:  Clifford A Lingwood
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

Review 3.  Role of glycosphingolipids in dendritic cell-mediated HIV-1 trans-infection.

Authors:  Wendy Blay Puryear; Suryaram Gummuluru
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

Review 4.  Roles for biological membranes in regulating human immunodeficiency virus replication and progress in the development of HIV therapeutics that target lipid metabolism.

Authors:  Norman J Haughey; Luis B Tovar-y-Romo; Veera Venkata Ratnam Bandaru
Journal:  J Neuroimmune Pharmacol       Date:  2011-03-29       Impact factor: 4.147

5.  A synthetic globotriaosylceramide analogue inhibits HIV-1 infection in vitro by two mechanisms.

Authors:  Amanda L Harrison; Martin L Olsson; R Brad Jones; Stephanie Ramkumar; Darinka Sakac; Beth Binnington; Stephen Henry; Clifford A Lingwood; Donald R Branch
Journal:  Glycoconj J       Date:  2010-06-26       Impact factor: 2.916

6.  Sphingolipids, cholesterol, and HIV-1: a paradigm in viral fusion.

Authors:  Satinder Singh Rawat; Mathias Viard; Stephen A Gallo; Robert Blumenthal; Anu Puri
Journal:  Glycoconj J       Date:  2006-05       Impact factor: 2.916

7.  Synthesis, gp120 binding and anti-HIV activity of fatty acid esters of 1,1-linked disaccharides.

Authors:  Stewart Bachan; Jacques Fantini; Anjali Joshi; Himanshu Garg; David R Mootoo
Journal:  Bioorg Med Chem       Date:  2011-07-01       Impact factor: 3.641

8.  Glycoside analogs of beta-galactosylceramide, a novel class of small molecule antiviral agents that inhibit HIV-1 entry.

Authors:  Himanshu Garg; Nicholas Francella; Kurissery A Tony; Line A Augustine; Joseph J Barchi; Jacques Fantini; Anu Puri; David R Mootoo; Robert Blumenthal
Journal:  Antiviral Res       Date:  2008-05-19       Impact factor: 5.970

Review 9.  The role of glycosphingolipids in HIV signaling, entry and pathogenesis.

Authors:  Mathias Viard; Isabella Parolini; Satinder S Rawat; Katia Fecchi; Massimo Sargiacomo; Anu Puri; Robert Blumenthal
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

10.  A Mycobacterium tuberculosis-derived lipid inhibits membrane fusion by modulating lipid membrane domains.

Authors:  Eri Hayakawa; Fuyuki Tokumasu; Glenn A Nardone; Albert J Jin; Vince A Hackley; James A Dvorak
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.